HEADER HYDROLASE/HYDROLASE INHIBITOR 28-MAY-21 5SAT TITLE ENDOTHIAPEPSIN IN COMPLEX WITH COMPOUND FU66-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTATE PROTEASE; COMPND 5 EC: 3.4.23.22 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPHONECTRIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESTNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116 KEYWDS FRAG4LEAD, FRAGMENT SCREENING, HYDROLASE, INHIBITION, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.WOLLENHAUPT,A.METZ,N.MESSINI,T.BARTHEL,G.KLEBE,M.S.WEISS REVDAT 3 23-OCT-24 5SAT 1 REMARK REVDAT 2 29-SEP-21 5SAT 1 JRNL REVDAT 1 01-SEP-21 5SAT 0 JRNL AUTH A.METZ,J.WOLLENHAUPT,S.GLOCKNER,N.MESSINI,S.HUBER,T.BARTHEL, JRNL AUTH 2 A.MERABET,H.D.GERBER,A.HEINE,G.KLEBE,M.S.WEISS JRNL TITL FRAG4LEAD: GROWING CRYSTALLOGRAPHIC FRAGMENT HITS BY CATALOG JRNL TITL 2 USING FRAGMENT-GUIDED TEMPLATE DOCKING. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 77 1168 2021 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 34473087 JRNL DOI 10.1107/S2059798321008196 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19_4092 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 62626 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.163 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3132 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.5900 - 3.9200 0.98 2792 147 0.1590 0.1861 REMARK 3 2 3.9200 - 3.1100 0.99 2761 146 0.1549 0.1909 REMARK 3 3 3.1100 - 2.7200 0.98 2693 141 0.1525 0.1728 REMARK 3 4 2.7200 - 2.4700 0.97 2680 142 0.1492 0.2080 REMARK 3 5 2.4700 - 2.2900 0.99 2725 143 0.1364 0.1844 REMARK 3 6 2.2900 - 2.1600 0.99 2737 144 0.1218 0.1550 REMARK 3 7 2.1600 - 2.0500 0.99 2723 143 0.1182 0.1562 REMARK 3 8 2.0500 - 1.9600 1.00 2748 145 0.1186 0.1734 REMARK 3 9 1.9600 - 1.8800 0.97 2675 141 0.1308 0.2087 REMARK 3 10 1.8800 - 1.8200 0.98 2703 142 0.1489 0.2382 REMARK 3 11 1.8200 - 1.7600 0.99 2724 143 0.1533 0.2138 REMARK 3 12 1.7600 - 1.7100 0.99 2712 143 0.1643 0.2314 REMARK 3 13 1.7100 - 1.6700 0.99 2687 142 0.1755 0.2604 REMARK 3 14 1.6700 - 1.6300 0.98 2705 142 0.1780 0.2355 REMARK 3 15 1.6300 - 1.5900 0.99 2743 144 0.1944 0.2564 REMARK 3 16 1.5900 - 1.5600 0.98 2692 142 0.2126 0.2973 REMARK 3 17 1.5600 - 1.5200 0.97 2653 140 0.2481 0.2982 REMARK 3 18 1.5200 - 1.5000 0.96 2622 138 0.2727 0.3286 REMARK 3 19 1.5000 - 1.4700 0.98 2688 141 0.2802 0.3227 REMARK 3 20 1.4700 - 1.4400 0.98 2704 142 0.2924 0.3438 REMARK 3 21 1.4400 - 1.4200 0.98 2641 140 0.3038 0.3712 REMARK 3 22 1.4200 - 1.4000 0.96 2686 141 0.3104 0.3315 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.194 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.352 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 2634 REMARK 3 ANGLE : 1.284 3632 REMARK 3 CHIRALITY : 0.095 426 REMARK 3 PLANARITY : 0.009 487 REMARK 3 DIHEDRAL : 6.484 412 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5SAT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1001404274. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62630 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 49.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.395 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.34 REMARK 200 R MERGE FOR SHELL (I) : 1.57900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.720 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NAAC PH 4.6, 0.1 M NH4AC PH 7.0, REMARK 280 27% (W/V) PEG 4000, 1.5µL PROTEIN + 1.5µL RESERVOIR + REMARK 280 0.1µL SEEDS, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.70000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -88 REMARK 465 SER A -87 REMARK 465 SER A -86 REMARK 465 PRO A -85 REMARK 465 LEU A -84 REMARK 465 LYS A -83 REMARK 465 ASN A -82 REMARK 465 ALA A -81 REMARK 465 LEU A -80 REMARK 465 VAL A -79 REMARK 465 THR A -78 REMARK 465 ALA A -77 REMARK 465 MET A -76 REMARK 465 LEU A -75 REMARK 465 ALA A -74 REMARK 465 GLY A -73 REMARK 465 GLY A -72 REMARK 465 ALA A -71 REMARK 465 LEU A -70 REMARK 465 SER A -69 REMARK 465 SER A -68 REMARK 465 PRO A -67 REMARK 465 THR A -66 REMARK 465 LYS A -65 REMARK 465 GLN A -64 REMARK 465 HIS A -63 REMARK 465 VAL A -62 REMARK 465 GLY A -61 REMARK 465 ILE A -60 REMARK 465 PRO A -59 REMARK 465 VAL A -58 REMARK 465 ASN A -57 REMARK 465 ALA A -56 REMARK 465 SER A -55 REMARK 465 PRO A -54 REMARK 465 GLU A -53 REMARK 465 VAL A -52 REMARK 465 GLY A -51 REMARK 465 PRO A -50 REMARK 465 GLY A -49 REMARK 465 LYS A -48 REMARK 465 TYR A -47 REMARK 465 SER A -46 REMARK 465 PHE A -45 REMARK 465 LYS A -44 REMARK 465 GLN A -43 REMARK 465 VAL A -42 REMARK 465 ARG A -41 REMARK 465 ASN A -40 REMARK 465 PRO A -39 REMARK 465 ASN A -38 REMARK 465 TYR A -37 REMARK 465 LYS A -36 REMARK 465 PHE A -35 REMARK 465 ASN A -34 REMARK 465 GLY A -33 REMARK 465 PRO A -32 REMARK 465 LEU A -31 REMARK 465 SER A -30 REMARK 465 VAL A -29 REMARK 465 LYS A -28 REMARK 465 LYS A -27 REMARK 465 THR A -26 REMARK 465 TYR A -25 REMARK 465 LEU A -24 REMARK 465 LYS A -23 REMARK 465 TYR A -22 REMARK 465 GLY A -21 REMARK 465 VAL A -20 REMARK 465 PRO A -19 REMARK 465 ILE A -18 REMARK 465 PRO A -17 REMARK 465 ALA A -16 REMARK 465 TRP A -15 REMARK 465 LEU A -14 REMARK 465 GLU A -13 REMARK 465 ASP A -12 REMARK 465 ALA A -11 REMARK 465 VAL A -10 REMARK 465 GLN A -9 REMARK 465 ASN A -8 REMARK 465 SER A -7 REMARK 465 THR A -6 REMARK 465 SER A -5 REMARK 465 GLY A -4 REMARK 465 LEU A -3 REMARK 465 ALA A -2 REMARK 465 GLU A -1 REMARK 465 ARG A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 129 -167.60 -77.82 REMARK 500 ALA A 320 172.92 -58.60 REMARK 500 REMARK 500 REMARK: NULL DBREF 5SAT A -88 330 UNP P11838 CARP_CRYPA 1 419 SEQRES 1 A 419 MET SER SER PRO LEU LYS ASN ALA LEU VAL THR ALA MET SEQRES 2 A 419 LEU ALA GLY GLY ALA LEU SER SER PRO THR LYS GLN HIS SEQRES 3 A 419 VAL GLY ILE PRO VAL ASN ALA SER PRO GLU VAL GLY PRO SEQRES 4 A 419 GLY LYS TYR SER PHE LYS GLN VAL ARG ASN PRO ASN TYR SEQRES 5 A 419 LYS PHE ASN GLY PRO LEU SER VAL LYS LYS THR TYR LEU SEQRES 6 A 419 LYS TYR GLY VAL PRO ILE PRO ALA TRP LEU GLU ASP ALA SEQRES 7 A 419 VAL GLN ASN SER THR SER GLY LEU ALA GLU ARG SER THR SEQRES 8 A 419 GLY SER ALA THR THR THR PRO ILE ASP SER LEU ASP ASP SEQRES 9 A 419 ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO ALA GLN SEQRES 10 A 419 THR LEU ASN LEU ASP PHE ASP THR GLY SER SER ASP LEU SEQRES 11 A 419 TRP VAL PHE SER SER GLU THR THR ALA SER GLU VAL ASP SEQRES 12 A 419 GLY GLN THR ILE TYR THR PRO SER LYS SER THR THR ALA SEQRES 13 A 419 LYS LEU LEU SER GLY ALA THR TRP SER ILE SER TYR GLY SEQRES 14 A 419 ASP GLY SER SER SER SER GLY ASP VAL TYR THR ASP THR SEQRES 15 A 419 VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN ALA VAL SEQRES 16 A 419 GLU SER ALA LYS LYS VAL SER SER SER PHE THR GLU ASP SEQRES 17 A 419 SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SER THR SEQRES 18 A 419 LEU ASN THR VAL SER PRO THR GLN GLN LYS THR PHE PHE SEQRES 19 A 419 ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL PHE THR SEQRES 20 A 419 ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR ASN PHE SEQRES 21 A 419 GLY PHE ILE ASP THR THR ALA TYR THR GLY SER ILE THR SEQRES 22 A 419 TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP GLU TRP SEQRES 23 A 419 THR SER THR GLY TYR ALA VAL GLY SER GLY THR PHE LYS SEQRES 24 A 419 SER THR SER ILE ASP GLY ILE ALA ASP THR GLY THR THR SEQRES 25 A 419 LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA TYR TRP SEQRES 26 A 419 ALA GLN VAL SER GLY ALA LYS SER SER SER SER VAL GLY SEQRES 27 A 419 GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SER PHE SEQRES 28 A 419 THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE PRO GLY SEQRES 29 A 419 ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SER SER SEQRES 30 A 419 SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY ILE GLY SEQRES 31 A 419 ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA ALA PHE SEQRES 32 A 419 VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU GLY PHE SEQRES 33 A 419 ALA SER LYS HET GOL A 501 14 HET ZSY A 502 42 HETNAM GOL GLYCEROL HETNAM ZSY N-CYCLOPROPYL-6-(FURAN-2-YL)-2-HYDROXY-N-[(PYRIDIN-2- HETNAM 2 ZSY YL)METHYL]PYRIDINE-3-CARBOXAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL C3 H8 O3 FORMUL 3 ZSY C19 H17 N3 O3 FORMUL 4 HOH *197(H2 O) HELIX 1 AA1 THR A 49 VAL A 53 5 5 HELIX 2 AA2 THR A 60 SER A 64 5 5 HELIX 3 AA3 SER A 113 ASP A 119 1 7 HELIX 4 AA4 PHE A 130 ASN A 134 5 5 HELIX 5 AA5 THR A 143 LYS A 149 1 7 HELIX 6 AA6 PRO A 228 ALA A 237 1 10 HELIX 7 AA7 PRO A 274 TYR A 277 5 4 HELIX 8 AA8 GLY A 306 LYS A 311 1 6 SHEET 1 AA1 9 LYS A 68 SER A 78 0 SHEET 2 AA1 9 SER A 84 VAL A 96 -1 O SER A 85 N ILE A 77 SHEET 3 AA1 9 TYR A 17 ILE A 23 -1 N GLN A 22 O SER A 95 SHEET 4 AA1 9 GLY A 3 PRO A 9 -1 N THR A 8 O ILE A 18 SHEET 5 AA1 9 GLY A 167 PHE A 171 -1 O GLY A 167 N THR A 7 SHEET 6 AA1 9 VAL A 156 ASP A 160 -1 N THR A 158 O ASN A 170 SHEET 7 AA1 9 PHE A 314 ASN A 318 -1 O PHE A 317 N PHE A 157 SHEET 8 AA1 9 THR A 324 ALA A 328 -1 O ALA A 328 N PHE A 314 SHEET 9 AA1 9 THR A 184 ALA A 187 -1 N THR A 184 O PHE A 327 SHEET 1 AA213 LYS A 68 SER A 78 0 SHEET 2 AA213 SER A 84 VAL A 96 -1 O SER A 85 N ILE A 77 SHEET 3 AA213 LEU A 99 VAL A 112 -1 O VAL A 106 N TYR A 90 SHEET 4 AA213 LEU A 41 VAL A 43 1 N LEU A 41 O GLU A 107 SHEET 5 AA213 GLY A 124 GLY A 127 -1 O LEU A 125 N TRP A 42 SHEET 6 AA213 GLN A 28 ASP A 35 1 N ASP A 35 O LEU A 126 SHEET 7 AA213 TYR A 17 ILE A 23 -1 N ILE A 23 O GLN A 28 SHEET 8 AA213 GLY A 3 PRO A 9 -1 N THR A 8 O ILE A 18 SHEET 9 AA213 GLY A 167 PHE A 171 -1 O GLY A 167 N THR A 7 SHEET 10 AA213 VAL A 156 ASP A 160 -1 N THR A 158 O ASN A 170 SHEET 11 AA213 PHE A 314 ASN A 318 -1 O PHE A 317 N PHE A 157 SHEET 12 AA213 THR A 324 ALA A 328 -1 O ALA A 328 N PHE A 314 SHEET 13 AA213 THR A 184 ALA A 187 -1 N THR A 184 O PHE A 327 SHEET 1 AA3 7 ALA A 269 ILE A 273 0 SHEET 2 AA3 7 PHE A 262 VAL A 266 -1 N PHE A 262 O ILE A 273 SHEET 3 AA3 7 GLU A 196 VAL A 204 -1 N ALA A 203 O THR A 263 SHEET 4 AA3 7 LYS A 210 ALA A 218 -1 O LYS A 210 N TYR A 202 SHEET 5 AA3 7 ASN A 303 PHE A 305 1 O PHE A 305 N ILE A 217 SHEET 6 AA3 7 LEU A 225 LEU A 227 -1 N TYR A 226 O ILE A 304 SHEET 7 AA3 7 ILE A 294 SER A 296 1 O GLN A 295 N LEU A 225 SHEET 1 AA4 4 LYS A 243 SER A 245 0 SHEET 2 AA4 4 GLY A 250 PRO A 254 -1 O GLY A 250 N SER A 245 SHEET 3 AA4 4 SER A 289 GLY A 292 -1 O CYS A 290 N PHE A 253 SHEET 4 AA4 4 ASP A 279 PRO A 282 -1 N GLY A 281 O PHE A 291 SSBOND 1 CYS A 255 CYS A 290 1555 1555 2.07 CISPEP 1 THR A 25 PRO A 26 0 -9.61 CISPEP 2 SER A 137 PRO A 138 0 5.59 CRYST1 45.170 73.400 52.560 90.00 109.37 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022139 0.000000 0.007783 0.00000 SCALE2 0.000000 0.013624 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020167 0.00000